×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MLTX – moonlake immunotherapeutics - class a ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MLTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
08:08 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
2/27
12:15 pm
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $82.00 to $73.00. They now have a "buy" rating on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $82.00 to $73.00. They now have a "buy" rating on the stock.
2/27
08:08 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its price target raised by analysts at Needham & Company LLC from $62.00 to $66.00. They now have a "buy" rating on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its price target raised by analysts at Needham & Company LLC from $62.00 to $66.00. They now have a "buy" rating on the stock.
2/27
08:08 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
2/26
10:55 am
mltx
MoonLake Immunotherapeutics reports Q4 results [Seeking Alpha]
Low
Report
MoonLake Immunotherapeutics reports Q4 results [Seeking Alpha]
2/26
07:00 am
mltx
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Medium
Report
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
2/20
12:26 pm
mltx
MoonLake Immunotherapeutics (MLTX): Among the Most Oversold Healthcare Stocks to Buy Now [Yahoo! Finance]
Low
Report
MoonLake Immunotherapeutics (MLTX): Among the Most Oversold Healthcare Stocks to Buy Now [Yahoo! Finance]
2/11
06:34 am
mltx
We're Hopeful That MoonLake Immunotherapeutics (NASDAQ:MLTX) Will Use Its Cash Wisely [Yahoo! Finance]
Medium
Report
We're Hopeful That MoonLake Immunotherapeutics (NASDAQ:MLTX) Will Use Its Cash Wisely [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
07:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
-1.6%
moonlake immunotherapeutics - class a ordinary shares
8/7/2024
08:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
-2.1%
moonlake immunotherapeutics - class a ordinary shares
5/7/2024
08:00 am
mltx
moonlake immunotherapeutics - class a ordinary shares
MISS
Report
-4.8%
moonlake immunotherapeutics - class a ordinary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/3
09:08 pm
mltx
Form 4 MoonLake Immunotherapeut For: Feb 27 Filed by: Santos da Silva Jorge
Low
Report
Form 4 MoonLake Immunotherapeut For: Feb 27 Filed by: Santos da Silva Jorge
3/3
09:07 pm
mltx
Form 4 MoonLake Immunotherapeut For: Feb 27 Filed by: Reich Kristian
Low
Report
Form 4 MoonLake Immunotherapeut For: Feb 27 Filed by: Reich Kristian
3/3
09:06 pm
mltx
Form 4 MoonLake Immunotherapeut For: Feb 27 Filed by: Bodenstedt Matthias
Low
Report
Form 4 MoonLake Immunotherapeut For: Feb 27 Filed by: Bodenstedt Matthias
2/26
07:13 am
mltx
Form 10-K MoonLake Immunotherapeut For: Dec 31
Medium
Report
Form 10-K MoonLake Immunotherapeut For: Dec 31
2/26
07:09 am
mltx
Form 8-K MoonLake Immunotherapeut For: Feb 26
Medium
Report
Form 8-K MoonLake Immunotherapeut For: Feb 26
2/14
09:44 am
mltx
Form SCHEDULE 13G MoonLake Immunotherapeut Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SCHEDULE 13G MoonLake Immunotherapeut Filed by: PRICE T ROWE ASSOCIATES INC /MD/
2/12
09:31 am
mltx
Form SCHEDULE 13G/A MoonLake Immunotherapeut Filed by: FMR LLC
Medium
Report
Form SCHEDULE 13G/A MoonLake Immunotherapeut Filed by: FMR LLC
1/22
09:56 pm
mltx
Form 4 MoonLake Immunotherapeut For: Jan 20 Filed by: Reich Kristian
Low
Report
Form 4 MoonLake Immunotherapeut For: Jan 20 Filed by: Reich Kristian
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: